Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Busy signal: platelet-derived growth factor activation in myelofibrosis.

Literature DB >> 32739885

Busy signal: platelet-derived growth factor activation in myelofibrosis.

Anna E Marneth¹, Ann Mullally^1,2,3.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2020 PMID： 32739885 PMCID： PMC7395275 DOI： 10.3324/haematol.2020.253708

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

20 in total

1. Inherited thrombocytopenias.

Authors: Alan T Nurden; Paquita Nurden
Journal: Haematologica Date: 2007-09 Impact factor: 9.941

2. Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms.

Authors: Simona Stivala; Tamara Codilupi; Sime Brkic; Anne Baerenwaldt; Nilabh Ghosh; Hui Hao-Shen; Stephan Dirnhofer; Matthias S Dettmer; Cedric Simillion; Beat A Kaufmann; Sophia Chiu; Matthew Keller; Maria Kleppe; Morgane Hilpert; Andreas S Buser; Jakob R Passweg; Thomas Radimerski; Radek C Skoda; Ross L Levine; Sara C Meyer
Journal: J Clin Invest Date: 2019-03-04 Impact factor: 14.808

Review 3. The PDGF/PDGFR pathway as a drug target.

Authors: Natalia Papadopoulos; Johan Lennartsson
Journal: Mol Aspects Med Date: 2017-11-15

4. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors: Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245

5. Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.

Authors: Alessandro M Vannucchi; Alessandro Pancrazzi; Paola Guglielmelli; Simonetta Di Lollo; Costanza Bogani; Gianna Baroni; Lucia Bianchi; Anna Rita Migliaccio; Alberto Bosi; Francesco Paoletti
Journal: Am J Pathol Date: 2005-09 Impact factor: 4.307

6. Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis.

Authors: Oliver Bock; Gero Loch; Guntram Büsche; Reinhard von Wasielewski; Jerome Schlué; Hans Kreipe
Journal: Haematologica Date: 2005-01 Impact factor: 9.941

7. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.

Authors: Jane F Apperley; Martine Gardembas; Junia V Melo; Robin Russell-Jones; Barbara J Bain; E Joanna Baxter; Andrew Chase; Judith M Chessells; Marie Colombat; Claire E Dearden; Sasa Dimitrijevic; François-X Mahon; David Marin; Zariana Nikolova; Eduardo Olavarria; Sandra Silberman; Beate Schultheis; Nicholas C P Cross; John M Goldman
Journal: N Engl J Med Date: 2002-08-15 Impact factor: 91.245

Review 1. Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants.

Authors: Elena Masselli; Giulia Pozzi; Giuliana Gobbi; Stefania Merighi; Stefania Gessi; Marco Vitale; Cecilia Carubbi
Journal: Cells Date: 2020-09-21 Impact factor: 6.600

1 in total